A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, UK, on March 8, 2024. Hollie Adams/ReutersGlobal pharmaceutical firm Novo Nordisk on Feb. 24 announced that as of Jan. 1, 2027, it will lower the list price, or wholesale acquisition cost, for its popular weight-loss drugs Ozempic and Wegovy by up to 50 percent.This will include Wegovy (semaglutide) 2.4 injections and 25 mg tablets, Ozempic (semaglutide) 0.5 mg, 1 mg, and 2 mg injections, and Rybelsus (semaglutide) 7 mg or 14 mg tablets to $675—equating to a reduction of nearly 50 percent for Wegovy and 35 percent of Ozempic from the current list prices.
Novo Nordisk to Cut Ozempic, Wegovy Prices Up to 50 Percent in US
Related Articles
EuropeThe Final wakeup call
Lula wins a miracle election in Brazil. Now comes the hard part: putting the country back on the right track
Three weeks ago, Brazilian President Luiz Inácio Lula da Silva’s political obituaries...
EuropeThe Final wakeup call
US midterms: what a new Congress could and could not change for Europe
US midterm elections traditionally attract fewer voters than presidential contests. But this...
EuropeThe Final wakeup call
Political power without balance leads to the erosion of democracy, what Montesquieu can teach modern-day France
KEY TAKEAWAYS Democratic erosion does not start by doing away with elections;...
China Business & EconomyChina NewsChina Technology
China Tech Index Plunges More Than 40 Percent From July Peak
China’s technology-heavy STAR 50 index has fallen by more than 40 percent...
